A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function (Q39782917)
Jump to navigation
Jump to search
scientific article published on 20 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function |
scientific article published on 20 September 2006 |
Statements
1 reference
A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function (English)
1 reference
Mihai Gheorghiade
1 reference
Jalal K Ghali
1 reference
William B Smith
1 reference
Guillermo Torre-Amione
1 reference
William Haynos
1 reference
Barry K Rayburn
1 reference
Antonino Amato
1 reference
Dan Zhang
1 reference
Doug Cowart
1 reference
Giovanni Valentini
1 reference
Paolo Carminati
1 reference
20 September 2006
1 reference
1 reference
Identifiers
1 reference